|Articles|December 1, 2000

December 2000
Volume 6
Issue 12

Determinants of Antidepressant Treatment Outcome

Author(s)Neeraj Sood, MS, Michael Treglia, PhD, Robert L. Obenchain, PhD, Brian Dulisse, PhD

Download PDF: Determinants of Antidepressant Treatment Outcome

Articles in this issue

over 25 years ago

Article

Impact of Birthweight on Healthcare Charges Within a Managed Care Organization

over 25 years ago

Article

Patient Preferences for Laboratory Test Results Notification

over 25 years ago

Article

Surviving the Prospective Payment System: Potential Problems and Solutions to Ensure Quality of Care

over 25 years ago

Article

Drugs and the Elderly, Part 1: The Problems Facing Managed Care

over 25 years ago

Article

The Role of Health Literacy in Narrowing the Treatment Gap for Hypercholesterolemia

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Determinants of Antidepressant Treatment Outcome

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

Medicaid MFN Pricing Could Save $8.6 Billion

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Active US Drug Shortages Rise for Third Straight Quarter

Cardiology Prices Vary Widely by Insurer and State

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise